Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
Pharma Marketing News Vol. 10, No. 14: 22 September 2011
Welcome to Volume 10, Issue #14 (22 SEPTEMBER 2011) of Pharma Marketing News.
BI Masters the Art of WOM through Its “Parrots,” er, Spokespersons
Even Social Media Savvy, Personable, Fun-Loving Boehringer Ingelheim (BI) Can Bring Shame to the Pharmaceutical Industry!
No sooner did I give Boehringer Ingelheim (BI) kudos...
BI’s Famously Buxom and Unpronounceable YouTube Video
"In this brave new world there are better marketing tools than Facebook o Twitter," says Ray Cokes (@raycokes), the actor who plays the "new...
Kevin Nalty Once Again Working Inside Pharma
I have chronicled the career of Kevin Nalty (aka "Nalts") for a number of years (see , for example, "Nalts Talks About His Days...
My New Business Card
"If you can't decode, hit the road!"
